Venus Medtech (Hangzhou) (HKSE:02500) Total Assets : HK$4,827.6 Mil (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Venus Medtech (Hangzhou) Total Assets?

Venus Medtech (Hangzhou)'s Total Assets for the quarter that ended in Dec. 2023 was HK$4,827.6 Mil.

Warning Sign:

If a company builds assets at 34.3% a year, faster than its revenue growth rate of 24% over the past 5 years, it means that the company may be getting less efficient.

During the past 12 months, Venus Medtech (Hangzhou)'s average Total Assets Growth Rate was 4.50% per year. During the past 3 years, the average Total Assets Growth Rate was 28.90% per year. During the past 5 years, the average Total Assets Growth Rate was 34.30% per year.

During the past 7 years, Venus Medtech (Hangzhou)'s highest 3-Year average Total Assets Growth Rate was 134.20%. The lowest was 28.90%. And the median was 39.15%.

Total Assets is connected with ROA %. Venus Medtech (Hangzhou)'s annualized ROA % for the quarter that ended in Dec. 2023 was -15.02%. Total Assets is also linked to Revenue through Asset Turnover. Venus Medtech (Hangzhou)'s Asset Turnover for the quarter that ended in Dec. 2023 was 0.05.

Venus Medtech (Hangzhou) Total Assets Historical Data

The historical data trend for Venus Medtech (Hangzhou)'s Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Venus Medtech (Hangzhou) Total Assets Chart

Venus Medtech (Hangzhou) Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Assets

Get a 7-Day Free Trial

4,082.47

5,118.97

6,256.36

5,899.42

4,827.63

Venus Medtech (Hangzhou) Semi-Annual Data
	Dec17	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Assets	Get a 7-Day Free Trial							6,256.36	7,423.95	5,899.42	5,468.44	4,827.63

Venus Medtech (Hangzhou) Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Venus Medtech (Hangzhou)'s Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (A: Dec. 2023 )	+	Total Liabilities (A: Dec. 2023 )
	=	3193.119	+	1634.508
	=	4,827.6

Venus Medtech (Hangzhou)'s Total Assets for the quarter that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (Q: Dec. 2023 )	+	Total Liabilities (Q: Dec. 2023 )
	=	3193.119	+	1634.508
	=	4,827.6

Venus Medtech (Hangzhou) (HKSE:02500) Total Assets Explanation

Total Assets is connected with ROA %.

Venus Medtech (Hangzhou)'s annualized ROA % for the quarter that ended in Dec. 2023 is

ROA %	=	Net Income (Q: Dec. 2023 )	/	( (Total Assets (Q: Jun. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
	=	-773.446	/	( (5468.44	+	4827.627)	/ 2 )
	=	-773.446	/	5148.0335
	=	-15.02 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Venus Medtech (Hangzhou)'s Asset Turnover for the quarter that ended in Dec. 2023 is

	Asset Turnover
=	Revenue (Q: Dec. 2023 )	/	( (Total Assets (Q: Jun. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
=	257.873	/	( (5468.44	+	4827.627)	/ 2 )
=	257.873	/	5148.0335
=	0.05

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Venus Medtech (Hangzhou) Total Assets Related Terms

Thank you for viewing the detailed overview of Venus Medtech (Hangzhou)'s Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Venus Medtech (Hangzhou) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Venus Medtech (Hangzhou) Inc (HKSE:02500) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 88, Jiangling Road, Room 311, 3rd Floor, Block 2, Binjiang District, Hangzhou, CHN, 310051

Website

https://www.venusmedtech.com

Venus Medtech (Hangzhou) Inc is engaged in the development and commercialization of transcatheter solutions for structural heart diseases. It has two TAVR products on the market, namely VenusA-Valve, and VenusA-Plus. VenusA-Valve is its first-generation TAVR device, which is used to treat severe Aortic Stenosis (AS) using a transcatheter approach. VenusA-Plus is an upgraded product of VenusA-Valve. Geographically all of the revenue is derived from Mainland China.

Executives

Zeng Min Frank	2201 Interest of corporation controlled by you
Zi Zhenjun	2201 Interest of corporation controlled by you
Ming Zhi Investments (bvi) Limited	2101 Beneficial owner
Ming Zhi Investments Limited	2201 Interest of corporation controlled by you
Qiming Venture Partners Iii, L.p.	2201 Interest of corporation controlled by you
Qiming Corporate Gp Iii, Ltd.	2201 Interest of corporation controlled by you
Qiming Gp Iii, L.p.	2201 Interest of corporation controlled by you
Dcp Capital Partners, L.p.	2201 Interest of corporation controlled by you
Dcp General Partner, Ltd	2201 Interest of corporation controlled by you
Dcp, Ltd.	2201 Interest of corporation controlled by you
Liu Haifeng David	2201 Interest of corporation controlled by you
Muheng Capital Partners (hong Kong) Limited	2101 Beneficial owner
Red Giant Limited	2201 Interest of corporation controlled by you
Wolhardt Julian Juul	2201 Interest of corporation controlled by you
Horizon Binjiang Llc	2101 Beneficial owner

Venus Medtech (Hangzhou) Headlines

No Headlines